Clinical Trials Directory

Trials / Unknown

UnknownNCT06064305

Transcriptional and Proteomic Analysis of Acute Kidney Injury

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
University Hospital Muenster · Academic / Other
Sex
All
Age
18 Years – 150 Years
Healthy volunteers

Summary

Acute kidney injury is associated with worsened outcome for critically ill patients. Sepsis-associated and non-septic cardiothoracic surgery associated AKI have been reported, nonetheless, precise pathomechanistic differences as well as detectability of transcriptional and proteomic changes in correlation with imaging and plasma markers are unclear.

Detailed description

Acute kidney injury is a common and detrimental finding in critically ill/sepsis patients as well as non-septic patients post cardiothoracic surgery. In many cases renal replacement therapy is required and an acute kidney injury is linked to increased morbidity and mortality in intensive care patients. Using routinely obtained clinical samples as well as imaging data, this observational trial investigates the transcriptomic and proteomic determinants detectable in septic and non-septic AKI patient subsets and their correlation with outcome and AKI diagnostic parameters.

Conditions

Interventions

TypeNameDescription
OTHERNo study-specific interventionsSeptic AKI patients, post-cardiothoracic AKI patients and non-AKI patients undergoing routine nephrectomy. Due to the observational design of the study, no study-specific interventions are performed. The treatment of the patients is completely guided by the responsible ICU physicians and the respective specialists.

Timeline

Start date
2023-09-29
Primary completion
2024-10-01
Completion
2024-12-01
First posted
2023-10-03
Last updated
2023-10-03

Source: ClinicalTrials.gov record NCT06064305. Inclusion in this directory is not an endorsement.